ASML vs ATRA · P/E 57, $665.37B cap vs rev $128.9M
ASML Holding NV ADR (ASML) versus Atara Biotherapeutics Inc (ATRA) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. ATRA currently screens at market cap $87.1M.
Not investment advice. Open the ASML and ATRA stock pages for the full models.
Not investment advice.